BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31455536)

  • 21. Structural Flexibility and Conformation Features of Cyclic Dinucleotides in Aqueous Solutions.
    Che X; Zhang J; Zhu Y; Yang L; Quan H; Gao YQ
    J Phys Chem B; 2016 Mar; 120(10):2670-80. PubMed ID: 26878265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of Original Cyclic Dinucleotide Analogues Using the Sulfo-click Reaction.
    Amador R; Vasseur JJ; Birkuš G; Bignon E; Monari A; Clavé G; Smietana M
    Org Lett; 2024 Feb; 26(4):819-823. PubMed ID: 38236576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structures of c-di-GMP/cGAMP degrading phosphodiesterase VcEAL: identification of a novel conformational switch and its implication.
    Yadav M; Pal K; Sen U
    Biochem J; 2019 Nov; 476(21):3333-3353. PubMed ID: 31647518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Group B Streptococcus Degrades Cyclic-di-AMP to Modulate STING-Dependent Type I Interferon Production.
    Andrade WA; Firon A; Schmidt T; Hornung V; Fitzgerald KA; Kurt-Jones EA; Trieu-Cuot P; Golenbock DT; Kaminski PA
    Cell Host Microbe; 2016 Jul; 20(1):49-59. PubMed ID: 27414497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct Dynamic and Conformational Features of Human STING in Response to 2'3'-cGAMP and c-di-GMP.
    Guo J; Wang J; Fan J; Zhang Y; Dong W; Chen CP
    Chembiochem; 2019 Jul; 20(14):1838-1847. PubMed ID: 30895657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No magnesium is needed for binding of the stimulator of interferon genes to cyclic dinucleotides.
    Smola M; Birkus G; Boura E
    Acta Crystallogr F Struct Biol Commun; 2019 Sep; 75(Pt 9):593-598. PubMed ID: 31475926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cGAS facilitates sensing of extracellular cyclic dinucleotides to activate innate immunity.
    Liu H; Moura-Alves P; Pei G; Mollenkopf HJ; Hurwitz R; Wu X; Wang F; Liu S; Ma M; Fei Y; Zhu C; Koehler AB; Oberbeck-Mueller D; Hahnke K; Klemm M; Guhlich-Bornhof U; Ge B; Tuukkanen A; Kolbe M; Dorhoi A; Kaufmann SH
    EMBO Rep; 2019 Apr; 20(4):. PubMed ID: 30872316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of phosphodiesterases that specifically degrade 3'3'-cyclic GMP-AMP.
    Gao J; Tao J; Liang W; Zhao M; Du X; Cui S; Duan H; Kan B; Su X; Jiang Z
    Cell Res; 2015 May; 25(5):539-50. PubMed ID: 25837739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzymatic Preparation of 2'-5',3'-5'-Cyclic Dinucleotides, Their Binding Properties to Stimulator of Interferon Genes Adaptor Protein, and Structure/Activity Correlations.
    Novotná B; Vaneková L; Zavřel M; Buděšínský M; Dejmek M; Smola M; Gutten O; Tehrani ZA; Pimková Polidarová M; Brázdová A; Liboska R; Štěpánek I; Vavřina Z; Jandušík T; Nencka R; Rulíšek L; Bouřa E; Brynda J; Páv O; Birkuš G
    J Med Chem; 2019 Dec; 62(23):10676-10690. PubMed ID: 31715099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential.
    Dejmek M; Šála M; Brazdova A; Vanekova L; Smola M; Klíma M; Břehová P; Buděšínský M; Dračínský M; Procházková E; Zavřel M; Šimák O; Páv O; Boura E; Birkuš G; Nencka R
    Structure; 2022 Aug; 30(8):1146-1156.e11. PubMed ID: 35690061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection.
    Barker JR; Koestler BJ; Carpenter VK; Burdette DL; Waters CM; Vance RE; Valdivia RH
    mBio; 2013 Apr; 4(3):e00018-13. PubMed ID: 23631912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational and NMR spectroscopy insights into the conformation of cyclic di-nucleotides.
    Wang B; Wang Z; Javornik U; Xi Z; Plavec J
    Sci Rep; 2017 Nov; 7(1):16550. PubMed ID: 29185472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Versatile modes of cellular regulation via cyclic dinucleotides.
    Krasteva PV; Sondermann H
    Nat Chem Biol; 2017 Mar; 13(4):350-359. PubMed ID: 28328921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SLC19A1 transports immunoreactive cyclic dinucleotides.
    Luteijn RD; Zaver SA; Gowen BG; Wyman SK; Garelis NE; Onia L; McWhirter SM; Katibah GE; Corn JE; Woodward JJ; Raulet DH
    Nature; 2019 Sep; 573(7774):434-438. PubMed ID: 31511694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Control of STING Agonistic/Antagonistic Activity Using Amine-Skeleton-Based c-di-GMP Analogues.
    Yanase Y; Tsuji G; Nakamura M; Shibata N; Demizu Y
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biotechnological production of cyclic dinucleotides-Challenges and opportunities.
    Bartsch T; Becker M; Rolf J; Rosenthal K; Lütz S
    Biotechnol Bioeng; 2022 Mar; 119(3):677-684. PubMed ID: 34953086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phage anti-CBASS protein simultaneously sequesters cyclic trinucleotides and dinucleotides.
    Cao X; Xiao Y; Huiting E; Cao X; Li D; Ren J; Fedorova I; Wang H; Guan L; Wang Y; Li L; Bondy-Denomy J; Feng Y
    Mol Cell; 2024 Jan; 84(2):375-385.e7. PubMed ID: 38103556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular cyclic dinucleotides induce polarized responses in barrier epithelial cells by adenosine signaling.
    Chang D; Whiteley AT; Bugda Gwilt K; Lencer WI; Mekalanos JJ; Thiagarajah JR
    Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27502-27508. PubMed ID: 33087577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligand Strain and Its Conformational Complexity Is a Major Factor in the Binding of Cyclic Dinucleotides to STING Protein.
    Smola M; Gutten O; Dejmek M; Kožíšek M; Evangelidis T; Tehrani ZA; Novotná B; Nencka R; Birkuš G; Rulíšek L; Boura E
    Angew Chem Int Ed Engl; 2021 Apr; 60(18):10172-10178. PubMed ID: 33616279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced immunostimulatory activity of cyclic dinucleotides on mouse cells when complexed with a cell-penetrating peptide or combined with CpG.
    Yildiz S; Alpdundar E; Gungor B; Kahraman T; Bayyurt B; Gursel I; Gursel M
    Eur J Immunol; 2015 Apr; 45(4):1170-9. PubMed ID: 25581346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.